Matches in Wikidata for { <http://www.wikidata.org/entity/Q76980556> ?p ?o ?g. }
Showing items 1 to 31 of
31
with 100 items per page.
- Q76980556 description "clinical trial" @default.
- Q76980556 description "ensayu clínicu" @default.
- Q76980556 description "klinisch onderzoek" @default.
- Q76980556 description "клінічне випробування" @default.
- Q76980556 name "Phase 3 Study of PF-06801591 in Combination With Bacillus Calmette-Guerin (BCG) in Participants With High-Risk Non-Muscle Invasive Bladder Cancer." @default.
- Q76980556 name "Phase 3 Study of PF-06801591 in Combination With Bacillus Calmette-Guerin" @default.
- Q76980556 type Item @default.
- Q76980556 label "Phase 3 Study of PF-06801591 in Combination With Bacillus Calmette-Guerin (BCG) in Participants With High-Risk Non-Muscle Invasive Bladder Cancer." @default.
- Q76980556 label "Phase 3 Study of PF-06801591 in Combination With Bacillus Calmette-Guerin" @default.
- Q76980556 prefLabel "Phase 3 Study of PF-06801591 in Combination With Bacillus Calmette-Guerin (BCG) in Participants With High-Risk Non-Muscle Invasive Bladder Cancer." @default.
- Q76980556 prefLabel "Phase 3 Study of PF-06801591 in Combination With Bacillus Calmette-Guerin" @default.
- Q76980556 P1132 Q76980556-328E5E1D-5E4C-4FFE-91BF-0FD572D5B6D4 @default.
- Q76980556 P1476 Q76980556-99C47DD4-994C-4996-A660-C792CB74561C @default.
- Q76980556 P1813 Q76980556-B80C7273-BED5-4543-83CA-B1901CB3F4EF @default.
- Q76980556 P2899 Q76980556-0F679A2E-46EC-4F64-9358-63EB00023BC1 @default.
- Q76980556 P3098 Q76980556-B6F657B9-F9DC-45D3-90A0-CA4A4474F805 @default.
- Q76980556 P31 Q76980556-8EBA50E1-2EB8-47A3-8E07-B6639D3861F1 @default.
- Q76980556 P580 Q76980556-5B1C5384-C103-4BC3-8B58-B6A1A605342D @default.
- Q76980556 P582 Q76980556-04E80C62-C8D8-4876-BCEF-B23E064184DB @default.
- Q76980556 P6099 Q76980556-F28BC61C-E798-4B27-BB75-1191B6FD8B6A @default.
- Q76980556 P8363 Q76980556-3DA332E9-66B0-4248-8B6A-DF951949EEA7 @default.
- Q76980556 P1132 "+999" @default.
- Q76980556 P1476 "A Phase 3, Multinational, Randomized, Open-Label, Three Parallel-Arm Study of PF-06801591, an Anti-PD-1 Antibody, in Combination With Bacillus Calmette-Guerin (BCG Induction With or Without BCG Maintenance) Versus BCG (Induction and Maintenance) in Participants With High-Risk, BCG Naïve Non-Muscle Invasive Bladder Cancer" @default.
- Q76980556 P1813 "B8011006" @default.
- Q76980556 P2899 "+18" @default.
- Q76980556 P3098 "NCT04165317" @default.
- Q76980556 P31 Q30612 @default.
- Q76980556 P580 "2019-12-23T00:00:00Z" @default.
- Q76980556 P582 "2024-05-31T00:00:00Z" @default.
- Q76980556 P6099 Q42824827 @default.
- Q76980556 P8363 Q78089383 @default.